Structural  ||| S:0 E:11 ||| JJ
Studies  ||| S:11 E:19 ||| NNS
of  ||| S:19 E:22 ||| IN
Component  ||| S:22 E:32 ||| NNP
of  ||| S:32 E:35 ||| IN
Lysoamidase  ||| S:35 E:47 ||| NNP
Bacteriolytic  ||| S:47 E:61 ||| NNP
Complex  ||| S:61 E:69 ||| NNP
from  ||| S:69 E:74 ||| IN
Lysobacter  ||| S:74 E:85 ||| NNP
sp ||| S:85 E:87 ||| NN
.  ||| S:87 E:89 ||| .
XL1  ||| S:89 E:93 ||| CD
The  ||| S:93 E:97 ||| DT
lysoamidase  ||| S:97 E:109 ||| JJ
bacteriolytic  ||| S:109 E:123 ||| JJ
complex  ||| S:123 E:131 ||| NN
( ||| S:131 E:132 ||| -LRB-
LBC ||| S:132 E:135 ||| NNP
)  ||| S:135 E:137 ||| -RRB-
comprising  ||| S:137 E:148 ||| VBG
five  ||| S:148 E:153 ||| CD
enzymes  ||| S:153 E:161 ||| NNS
( ||| S:161 E:162 ||| -LRB-
L1-L5 ||| S:162 E:167 ||| NNP
)  ||| S:167 E:169 ||| -RRB-
is  ||| S:169 E:172 ||| VBZ
secreted  ||| S:172 E:181 ||| VBN
into  ||| S:181 E:186 ||| IN
the  ||| S:186 E:190 ||| DT
culture  ||| S:190 E:198 ||| NN
liquid  ||| S:198 E:205 ||| NN
by  ||| S:205 E:208 ||| IN
gram-negative  ||| S:208 E:222 ||| JJ
bacterium  ||| S:222 E:232 ||| NN
Lysobacter  ||| S:232 E:243 ||| NNP
sp ||| S:243 E:245 ||| NN
.  ||| S:245 E:247 ||| .
XL1 ||| S:247 E:250 ||| NNP
.  ||| S:250 E:252 ||| .
The  ||| S:252 E:256 ||| DT
medicinal  ||| S:256 E:266 ||| JJ
agent  ||| S:266 E:272 ||| NN
lysoamidase  ||| S:272 E:284 ||| NN
has  ||| S:284 E:288 ||| VBZ
a  ||| S:288 E:290 ||| DT
broad-antimicrobial  ||| S:290 E:310 ||| JJ
spectrum ||| S:310 E:318 ||| NN
.  ||| S:318 E:320 ||| .
Bacteriolytic  ||| S:320 E:334 ||| FW
protease  ||| S:334 E:343 ||| FW
L1  ||| S:343 E:346 ||| FW
belongs  ||| S:346 E:354 ||| VBZ
to  ||| S:354 E:357 ||| TO
the  ||| S:357 E:361 ||| DT
LBC ||| S:361 E:364 ||| NNP
.  ||| S:364 E:366 ||| .
Recombinant  ||| S:366 E:378 ||| NNP
L1  ||| S:378 E:381 ||| NNP
protease  ||| S:381 E:390 ||| NN
of  ||| S:390 E:393 ||| IN
Lysobacter  ||| S:393 E:404 ||| NNP
sp ||| S:404 E:406 ||| NN
.  ||| S:406 E:408 ||| .
XL1  ||| S:408 E:412 ||| NNP
was  ||| S:412 E:416 ||| VBD
expressed ||| S:416 E:425 ||| VBN
,  ||| S:425 E:427 ||| ,
purified  ||| S:427 E:436 ||| VBG
to  ||| S:436 E:439 ||| TO
homogeneity  ||| S:439 E:451 ||| VB
and  ||| S:451 E:455 ||| CC
crystallized ||| S:455 E:467 ||| NN
.  ||| S:467 E:469 ||| .
The  ||| S:469 E:473 ||| DT
X-ray  ||| S:473 E:479 ||| NN
structure  ||| S:479 E:489 ||| NN
of  ||| S:489 E:492 ||| IN
L1  ||| S:492 E:495 ||| CD
at  ||| S:495 E:498 ||| IN
1.35 Å  ||| S:498 E:505 ||| CD
resolution  ||| S:505 E:516 ||| NN
has  ||| S:516 E:520 ||| VBZ
been  ||| S:520 E:525 ||| VBN
determined  ||| S:525 E:536 ||| VBN
using  ||| S:536 E:542 ||| VBG
the  ||| S:542 E:546 ||| DT
synchrotron  ||| S:546 E:558 ||| JJ
data  ||| S:558 E:563 ||| NNS
and  ||| S:563 E:567 ||| CC
the  ||| S:567 E:571 ||| DT
molecular  ||| S:571 E:581 ||| JJ
replacement  ||| S:581 E:593 ||| NN
method ||| S:593 E:599 ||| NN
.  ||| S:599 E:601 ||| .
L1  ||| S:601 E:604 ||| NNP
protease  ||| S:604 E:613 ||| NN
is  ||| S:613 E:616 ||| VBZ
a  ||| S:616 E:618 ||| DT
thermostable  ||| S:618 E:631 ||| NN
whose  ||| S:631 E:637 ||| WP$
thermal  ||| S:637 E:645 ||| JJ
unfolding  ||| S:645 E:655 ||| JJ
proceeds  ||| S:655 E:664 ||| NNS
in  ||| S:664 E:667 ||| IN
one  ||| S:667 E:671 ||| CD
step  ||| S:671 E:676 ||| NN
without  ||| S:676 E:684 ||| IN
forming  ||| S:684 E:692 ||| VBG
stable  ||| S:692 E:699 ||| JJ
intermediates ||| S:699 E:712 ||| NN
.  ||| S:712 E:714 ||| .
Structural  ||| S:714 E:725 ||| JJ
information  ||| S:725 E:737 ||| NN
concerning  ||| S:737 E:748 ||| VBG
L1  ||| S:748 E:751 ||| NNP
will  ||| S:751 E:756 ||| MD
contribute  ||| S:756 E:767 ||| VB
to  ||| S:767 E:770 ||| TO
the  ||| S:770 E:774 ||| DT
development  ||| S:774 E:786 ||| NN
of  ||| S:786 E:789 ||| IN
new-generation  ||| S:789 E:804 ||| NN
antimicrobial  ||| S:804 E:818 ||| NN
drugs ||| S:818 E:823 ||| NNS
,  ||| S:823 E:825 ||| ,
whose  ||| S:825 E:831 ||| WP$
application  ||| S:831 E:843 ||| NN
will  ||| S:843 E:848 ||| MD
not  ||| S:848 E:852 ||| RB
be  ||| S:852 E:855 ||| VB
accompanied  ||| S:855 E:867 ||| VBN
by  ||| S:867 E:870 ||| IN
the  ||| S:870 E:874 ||| DT
selection  ||| S:874 E:884 ||| NN
of  ||| S:884 E:887 ||| IN
resistant  ||| S:887 E:897 ||| JJ
microorganisms ||| S:897 E:911 ||| NN
.  ||| S:911 E:913 ||| .
